Development and validation of an LC-MS/MS method for identification and quantitation of emerging fusarium and alternaria mycotoxins in livestock and pet feed

Active Cooperative Agreement Awarded

Award ID
U18FD008923
Recipient
Awarding agency
Obligated
$50,000

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date 8% complete
Funding agency
Food and Drug Administration Department of Health and Human Services
Place of performance
Davis, CA, USA

Award details come from USAspending.gov.

Description

Abstract
Emerging mycotoxins are a group of mycotoxins which have been identified more recently, primarily described from fusarium and alternaria, and include: beauvericin (BEA), enniatins (ENNS), moniliformin (MON), alternariol (AOH), alternariol monoethyl ether (AME), and tenuazonic acid (tea), among OTHERS20-21. They are not regulated or routinely analyzed for, but have been widely observed in cereals and cereal by-products, as well as in pet food and animal FEED3,9,10,12,13,20-26. Toxicology data for these emerging mycotoxins is incomplete, and this has limited the evaluation of their risks in most cases, especially in companion animals and a number of livestock ANIMALS9,22,25-27. Given the gaps in toxicology data, analytical methods are critically needed to evaluate emerging mycotoxin levels in pet food and livestock feed. A robust, well-validated, comprehensive analytical method for emerging toxin analysis in both pet food and livestock feed is needed by VET-lirn labs for surveillance and investigate work. Our project has two specific aims to achieve this, as described below: specific aim #1: to develop and fully validate a method for the detection and quantitation of representative fusarium and alternaria mycotoxins, at relevant levels (low PPB to PPM) in pet food and livestock feed, which can be used for routine monitoring of these compounds and investigative work. The method will utilize liquid chromatography-tandem mass spectrometry (LC-MS/MS) and/or liquid chromatography-high resolution mass spectrometry (LC-HRMS) for the detection and quantitation of representative fusarium and alternaria emerging mycotoxins, including: BEA, ENN (type B), MON, AOH, AME, and tea. Both pet food and livestock feed will be assessed. We will validate the method using FDA level 2 guidelines for single lab validation, determining relevant parameters. Specific aim #2: to successfully complete a single lab blinded method test (BMT) using the validated method. We will participate in a single lab BMT with VET-lirn to further demonstrate the robustness of the validated method. The specific matrices and levels will be determined in consultation between VET- lirn and cahfs, and designed for relevance for routing monitoring and investigative applications. Upon successful completion, the method will be made available for sharing with other VET-lirn labs, and cahfs will maintain the capabilities for analyzing samples using the method. Cahfs is also open to participating in a multi-lab validation. This method will increase the capabilities of our lab and VET-lirn to respond to food and feed emergencies, and will support the FDA in its mission of protecting companion animal and livestock health, as well as contributing to increased food and feed safety.

Quick answers

Who received award U18FD008923?

U18FD008923 was awarded to University Of California, Davis by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.

How much is award U18FD008923 worth?

$50,000 has been obligated on U18FD008923.

Which agency awarded U18FD008923?

FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008923, with funding from Food and Drug Administration (Department of Health and Human Services).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award